Tel Aviv, Israel

Albert Pinhasov


Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2003-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Albert Pinhasov: Innovator in Orally Active Peptides

Introduction

Albert Pinhasov is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of orally active peptides that prevent cell damage and death. With a total of 3 patents to his name, his work has the potential to impact various medical conditions.

Latest Patents

One of Albert Pinhasov's latest inventions involves an ADNF polypeptide that comprises an active core site, which includes at least one D-amino acid. This invention also encompasses a pharmaceutical composition that is orally active. The applications of this invention are profound, as it provides methods for reducing neuronal cell death, mitigating oxidative stress, and addressing conditions associated with fetal alcohol syndrome through the use of ADNF polypeptides and the associated pharmaceutical compositions.

Career Highlights

Throughout his career, Albert Pinhasov has worked with esteemed organizations, including the National Institute of Health. His innovative research has positioned him as a key figure in the development of therapeutic solutions aimed at improving health outcomes.

Collaborations

Albert has collaborated with notable individuals in his field, including Illana Gozes and Douglas E Brenneman. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Albert Pinhasov's work in the realm of orally active peptides showcases his dedication to innovation in the pharmaceutical industry. His inventions hold promise for addressing critical health issues, and his contributions continue to be recognized in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…